TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from LTR Pharma Limited ( (AU:LTP) ) is now available.
LTR Pharma Limited has announced the nationwide availability of its product SPONTAN through TerryWhite Chemmart’s extensive pharmacy network, marking a significant step in expanding patient access. This move is part of a strategic partnership with Symbion Pty Ltd, enhancing LTR Pharma’s operational readiness and data collection capabilities, which supports their regulatory strategy and future commercial launches.
More about LTR Pharma Limited
LTR Pharma Limited operates in the pharmaceutical industry, focusing on expanding patient access to medications through partnerships and pharmacy networks. The company is involved in developing and distributing pharmaceutical products, with a market focus on enhancing accessibility and integration with healthcare systems.
Average Trading Volume: 686,165
Technical Sentiment Signal: Sell
See more insights into LTP stock on TipRanks’ Stock Analysis page.